Finance

Lists
Why is AEON down 11,01%?
Dive Deeper
AEON:NYSEAMERICAN
Aeon Biopharma Inc
0,25 $
-11,01%
(-0,030) 1D
0,25 $
+0,45% (+0,0011)
After hours
Closed: 12 հոկ, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AEON...
Open
0,27 $
High
0,28 $
Low
0,24 $
Mkt. cap
12,08 մլն
Avg. vol.
13,06 մլն
Volume
1,07 մլն
52-wk high
1,45 $
52-wk low
0,18 $
EPS
-3,58 $
Beta
0,69
Shares outstanding
49,88 մլն
No. of employees
8
Open
0,27 $
High
0,28 $
Low
0,24 $
Mkt. cap
12,08 մլն
Avg. vol.
13,06 մլն
Volume
1,07 մլն
52-wk high
1,45 $
52-wk low
0,18 $
EPS
-3,58 $
Beta
0,69
Shares outstanding
49,88 մլն
No. of employees
8
News stories
From web sources and news partners
Profile
Alphaeon Corporation is a company focused on healthcare products and services based in Irvine, California. Alphaeon Corporation serves healthcare providers in the self-pay segment; primarily plastic surgery, ophthalmology, dentistry, and dermatology. Wikipedia
About Aeon Biopharma Inc
CEOMurthy Simhambhatla
Employees8
Founded2013
HeadquartersԻրվայն, Կալիֆոռնիա, Միացյալ Նահանգներ
Sector-
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
597,00 հզր
1,61 մլն
2,03 մլն
2,94 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,33 մլն
3,49 մլն
3,90 մլն
2,99 մլն
Operating expense
2,93 մլն
5,10 մլն
5,94 մլն
5,93 մլն
Total operating expenses
2,93 մլն
5,10 մլն
5,94 մլն
5,93 մլն
Operating income
-2,93 մլն
-5,10 մլն
-5,94 մլն
-5,93 մլն
Other non operating income
-168,00 հզր
-14,08 մլն
2,94 մլն
4,98 մլն
EBT including unusual items
-4,54 մլն
-37,14 մլն
-11,79 մլն
-1,16 մլն
EBT excluding unusual items
-3,10 մլն
-19,18 մլն
-2,99 մլն
-952,00 հզր
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-4,54 մլն
-37,14 մլն
-11,79 մլն
-1,16 մլն
Net profit margin
-
-
-
-
Earnings per share
-0,39
-3,72
-0,25
-0,02
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-2,91 մլն
-5,08 մլն
-5,92 մլն
-5,91 մլն
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google Apps